acetaminophen has been researched along with exenatide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bloom, SR; Brynes, AE; Davis, R; Edwards, CM; Frost, GS; Ghatei, MA; Seal, LJ; Stanley, SA | 1 |
| Aisporna, M; Baron, AD; Bicsak, TA; Buse, JB; Fineman, MS; Gaines, E; Heintz, S; Kim, D; Kolterman, OG; Taylor, K; Wang, Y | 1 |
| Blase, E; Fineman, M; Gao, HY; Taylor, K; Wintle, M | 1 |
| Cersosimo, E; Cervera, A; DeFronzo, RA; Fernandez, M; Musi, N; Sriwijitkamol, A; Triplitt, C; Wajcberg, E; Zuo, P | 1 |
| Alejandro, R; Corrales, A; Froud, T; Gomes, LS; Herrada, E; Peixoto, EM; Ricordi, C; Zavala, LM | 1 |
| Andrews, S; Chism, J; Choudhury, A; Hodge, RJ; Lin, J; Nunez, DJ; O'Connor-Semmes, RL | 1 |
1 review(s) available for acetaminophen and exenatide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for acetaminophen and exenatide
| Article | Year |
|---|---|
Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Fasting; Female; Gastric Emptying; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Peptides; Postprandial Period; Triglycerides; Venoms | 2003 |
Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects.
Topics: Acetaminophen; Administration, Oral; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Area Under Curve; Cross-Over Studies; Drug Interactions; Exenatide; Female; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Male; Middle Aged; Peptides; Single-Blind Method; Venoms | 2005 |
GSK2374697, a novel albumin-binding domain antibody (AlbudAb), extends systemic exposure of exendin-4: first study in humans--PK/PD and safety.
Topics: Acetaminophen; Adult; Aged; Antibodies; Blood Glucose; Exenatide; Female; Gastric Emptying; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Male; Middle Aged; Nausea; Peptides; Protein Binding; Receptors, Glucagon; Recombinant Fusion Proteins; Serum Albumin; Venoms | 2014 |
3 other study(ies) available for acetaminophen and exenatide
| Article | Year |
|---|---|
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Animals; Area Under Curve; Blood Glucose; Depression, Chemical; Energy Intake; Energy Metabolism; Exenatide; Fasting; Female; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Hormones; Humans; Infusions, Intravenous; Insulin; Lizards; Male; Nausea; Peptide Fragments; Peptides; Postprandial Period; Protein Precursors; Satiety Response; Venoms | 2001 |
Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Blood Glucose; Diabetes Mellitus, Type 2; Exenatide; Female; Gastric Emptying; Glucagon; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Peptides; Postprandial Period; Triglycerides; Venoms | 2008 |
Effect of exenatide on gastric emptying and graft survival in islet allograft recipients.
Topics: Acetaminophen; C-Peptide; Cell Transplantation; Cohort Studies; Dose-Response Relationship, Drug; Exenatide; Gastric Emptying; Glucose; Graft Survival; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Peptides; Venoms | 2011 |